<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/cancers11060808</dc:identifier><dc:language>eng</dc:language><dc:creator>Dufait, Inès</dc:creator><dc:creator>Pardo, Julián</dc:creator><dc:creator>Escors, David</dc:creator><dc:creator>De Vlaeminck, Yannick</dc:creator><dc:creator>Jiang, Heng</dc:creator><dc:creator>Keyaerts, Marleen</dc:creator><dc:creator>De Ridder, Mark</dc:creator><dc:creator>Breckpot, Karine</dc:creator><dc:title>Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells</dc:title><dc:identifier>ART-2019-115388</dc:identifier><dc:description>A wide-range of myeloid-derived suppressor cell (MDSC)-mediated immune suppressive functions has previously been described. Nevertheless, potential novel mechanisms by which MDSCs aid tumor progression are, in all likelihood, still unrecognized. Next to its well-known expression in natural killer cells and cytotoxic T lymphocytes (CTLs), granzyme B (GzmB) expression has been found in different cell types. In an MDSC culture model, we demonstrated perforin and GzmB expression. Furthermore, similar observations were made in MDSCs isolated from tumor-bearing mice. Even in MDSCs from humans, GzmB expression was demonstrated. Of note, B16F10 melanoma cells co-cultured with perforin/GzmB knock out mice (KO) MDSCs displayed a remarkable decrease in invasive potential. B16F10 melanoma cells co-injected with KO MDSCs, displayed a significant slower growth curve compared to tumor cells co-injected with wild type (WT) MDSCs. In vivo absence of perforin/GzmB in MDSCs resulted in a higher number of CD8+ T-cells. Despite this change in favor of CD8+ T-cell infiltration, we observed low interferon-¿ (IFN-¿) and high programmed death-ligand 1 (PD-L1) expression, suggesting that other immunosuppressive mechanisms render these CD8+ T-cells dysfunctional. Taken together, our results suggest that GzmB expression in MDSCs is another means to promote tumor growth and warrants further investigation to unravel the exact underlying mechanism.</dc:description><dc:date>2019</dc:date><dc:source>http://zaguan.unizar.es/record/86997</dc:source><dc:doi>10.3390/cancers11060808</dc:doi><dc:identifier>http://zaguan.unizar.es/record/86997</dc:identifier><dc:identifier>oai:zaguan.unizar.es:86997</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B29</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/SAF2017-83120-C2-1-R</dc:relation><dc:identifier.citation>Cancers 11, 6 (2019), 808  [17 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>